Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| RADI | P35241 | Radixin | Disease related genesHuman disease related genesPredicted intracellular proteins | DeafnessNon-syndromic deafness | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 13 | 0.60 | |||
| NEXN | Q0ZGT2 | Nexilin (F-actin-binding protein) (Nelin) | Disease related genesHuman disease related genesPredicted intracellular proteins | Cardiomyopathy | Adhesion and uptake mediationFusion and delivery mediation | 12 | 0.60 | |||
| MAP2 | P50579 | Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) | EnzymesEssential proteinsPlasma proteins | Diabetes mellitusObesitySolid tumour/cancer | Clinical-translation mediationMetabolism mediation | 11 | 0.60 | |||
| NLGN1 | Q8N2Q7 | Neuroligin-1 | Disease related genesHuman disease related genesPotential drug targets | 1 | AutismAutism spectrum disorder | Adhesion and uptake mediationFusion and delivery mediation | 11 | 0.60 | ||
| CD33 | P20138 | Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33) | CD markersFDA approved drug targetsPlasma proteins | 1 | Acute myeloid leukaemiaAlzheimer diseaseBCR-ABL1-negative chronic myeloid leukaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.53 | ||
| CD4 | P01730 | T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4) | CD markersDisease related genesFDA approved drug targets | 1 | Acute myeloid leukaemiaAsthmaHuman immunodeficiency virus disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | ||
| CD59 | P13987 | CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59) | Cancer-related genesCD markersDisease related genes | Hereditary hemolytic anemiaMacular degenerationRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.53 | |||
| COG3 | Q96JB2 | Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) | Essential proteinsPredicted intracellular proteins | Congenital disorder of glycosylation | Fusion and delivery mediationMetabolism mediation | 5 | 0.53 | |||
| CRLF2 | Q9HC73 | Cytokine receptor-like factor 2 (Cytokine receptor-like 2) (IL-XR) (Thymic stromal lymphopoietin protein receptor) (TSLP receptor) | 1 | Asthma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.53 | |||
| DYSF | O75923 | Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1) | Disease related genesHuman disease related genesPotential drug targets | 1 | Limb-girdle muscular dystrophyMuscular dystrophy | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.53 |